Title
Bat and lyssavirus exposure among humans in area that celebrates bat festival, Nigeria, 2010 and 2013
Date Issued
01 July 2020
Access level
open access
Resource Type
journal article
Author(s)
Vora N.M.
Osinubi M.O.V.
Davis L.
Abdurrahman M.
Adedire E.B.
Akpan H.
Aman-Oloniyo A.F.
Audu S.W.
Blau D.
Dankoli R.S.
Ehimiyein A.M.
Ellison J.A.
Gbadegesin Y.H.
Greenberg L.
Haberling D.
Hutson C.
Idris J.M.
Kia G.S.N.
Lawal M.
Matthias S.Y.
Mshelbwala P.P.
Niezgoda M.
Ogunkoya A.B.
Ogunniyi A.O.
Okara G.C.
Olugasa B.O.
Ossai O.P.
Oyemakinde A.
Person M.K.
Rupprecht C.E.
Saliman O.A.
Sani M.
Sanni-Adeniyi O.A.
Satheshkumar P.S.
Smith T.G.
Soleye M.O.
Wallace R.M.
Yennan S.K.
Centers for Disease Control and Prevention
Publisher(s)
Centers for Disease Control and Prevention (CDC)
Abstract
Using questionnaires and serologic testing, we evaluated bat and lyssavirus exposure among persons in an area of Nigeria that celebrates a bat festival. Bats from festival caves underwent serologic testing for phylogroup II lyssaviruses (Lagos bat virus, Shimoni bat virus, Mokola virus). The enrolled households consisted of 2,112 persons, among whom 213 (10%) were reported to have ever had bat contact (having touched a bat, having been bitten by a bat, or having been scratched by a bat) and 52 (2%) to have ever been bitten by a bat. Of 203 participants with bat contact, 3 (1%) had received rabies vaccination. No participant had neutralizing antibodies to phylogroup II lyssaviruses, but ≥50% of bats had neutralizing antibodies to these lyssaviruses. Even though we found no evidence of phylogroup II lyssavirus exposure among humans, persons interacting with bats in the area could benefit from practicing bat-related health precautions.
Start page
1399
End page
1408
Volume
26
Issue
7
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Scopus EID
2-s2.0-85086849986
PubMed ID
Source
Emerging Infectious Diseases
ISSN of the container
10806040
Sponsor(s)
This study was supported by the Biosecurity Engagement Program of the US Department of State, Bureau of International Security and Nonproliferation, and the Office of Cooperative Threat Reduction’s Global Threat Reduction Programs; One Health funding; and the Global Disease Detection Program of the Center for Global Health at CDC.
Sources of information:
Directorio de Producción Científica
Scopus